Discontinuation of treatment of schizophrenic patients is driven by poor symptom response: a pooled post-hoc analysis of four atypical antipsychotic drugs

Por Liu-Seifert, Hong, Adams, David H, Kinon, Bruce J
Publicado em 2005

Acute weight gain, gender, and therapeutic response to antipsychotics in the treatment of patients with schizophrenia

Por Ascher-Svanum, Haya, Stensland, Michael, Zhao, Zhongyun, Kinon, Bruce J
Publicado em 2005

Effectiveness and medication acceptance of olanzapine disintegrating tablets compared to standard olanzapine tablets in acutely treated psychiatric patients

Por Czekalla, Jörg, Wagner, Thomas, Schacht, Alexander, Kluge, Michael, Kinon, Bruce
Publicado em 2007

Clinical and economic ramifications of switching antipsychotics in the treatment of schizophrenia

Por Faries, Douglas E, Ascher-Svanum, Haya, Nyhuis, Allen W, Kinon, Bruce J
Publicado em 2009

The Burden of Depressive Symptoms in the Long-Term Treatment of Patients With Schizophrenia

Por Conley, Robert R., Ascher-Svanum, Haya, Zhu, Baojin, Faries, Douglas, Kinon, Bruce J.
Publicado em 2006

Sexual dysfunction in patients with schizophrenia treated with conventional antipsychotics or risperidone

Por Liu-Seifert, Hong, Kinon, Bruce J, Tennant, Christopher J, Sniadecki, Jennifer, Volavka, Jan
Publicado em 2009

A Short-Term, Multicenter, Placebo-Controlled, Randomized Withdrawal Study of a Metabotropic Glutamate 2/3 Receptor Agonist Using an Electronic Patient-Reported Outcome Device in P...

Por Stauffer, Virginia L., Baygani, Simin K., Kinon, Bruce J., Krikke-Workel, Judith O.
Publicado em 2014

Pomaglumetad Methionil (LY2140023 Monohydrate) and Aripiprazole in Patients with Schizophrenia: A Phase 3, Multicenter, Double-Blind Comparison

Por Adams, David H., Zhang, Lu, Millen, Brian A., Kinon, Bruce J., Gomez, Juan-Carlos
Publicado em 2014

Patient perception of medication benefit and early treatment discontinuation in a 1-year study of patients with schizophrenia

Por Liu-Seifert, Hong, Adams, David H, Ascher-Svanum, Haya, Faries, Douglas E, Kinon, Bruce J
Publicado em 2007

Involvement in the US criminal justice system and cost implications for persons treated for schizophrenia

Por Ascher-Svanum, Haya, Nyhuis, Allen W, Faries, Douglas E, Ball, Daniel E, Kinon, Bruce J
Publicado em 2010

Predictors of switching antipsychotic medications in the treatment of schizophrenia

Por Nyhuis, Allen W, Faries, Douglas E, Ascher-Svanum, Haya, Stauffer, Virginia L, Kinon, Bruce J
Publicado em 2010

Predictors and correlates for weight changes in patients co-treated with olanzapine and weight mitigating agents; a post-hoc analysis

Por Heinloth Alexandra N, Hoffmann Vicki, Lipkovich Ilya, Stauffer Virginia L, McGregor H Scott, Kinon Bruce J
Publicado em 2009-03-01

Clinical, Functional, and Economic Ramifications of Early Nonresponse to Antipsychotics in the Naturalistic Treatment of Schizophrenia

Por Ascher-Svanum, Haya, Nyhuis, Allen W., Faries, Douglas E., Kinon, Bruce J., Baker, Robert W., Shekhar, Anantha
Publicado em 2008

Construct validity of 2 measures to assess reasons for antipsychotic discontinuation and continuation from patients’ and clinicians’ perspectives in a clinical trial

Por Faries, Douglas, Ascher-Svanum, Haya, Phillips, Glenn, Nyhuis, Allen W, Sugihara, Tomoko, Stauffer, Virginia, Kinon, Bruce J
Publicado em 2012

Predictors and correlates for weight changes in patients co-treated with olanzapine and weight mitigating agents; a post-hoc analysis

Por Stauffer, Virginia L, Lipkovich, Ilya, Hoffmann, Vicki Poole, Heinloth, Alexandra N, McGregor, H Scott, Kinon, Bruce J
Publicado em 2009

Long-term healthcare costs and functional outcomes associated with lack of remission in schizophrenia: a post-hoc analysis of a prospective observational study

Por Haynes, Virginia S, Zhu, Baojin, Stauffer, Virginia L, Kinon, Bruce J, Stensland, Michael D, Xu, Lei, Ascher-Svanum, Haya
Publicado em 2012

The longitudinal interplay between negative and positive symptom trajectories in patients under antipsychotic treatment: a post hoc analysis of data from a randomized, 1-year pragm...

Por Chen, Lei, Johnston, Joseph A, Kinon, Bruce J, Stauffer, Virginia, Succop, Paul, Marques, Tiago R, Ascher-Svanum, Haya
Publicado no BMC Psychiatry (2013)

The relationship, structure and profiles of schizophrenia measurements: a post-hoc analysis of the baseline measures from a randomized clinical trial

Por Chen Lei, Phillips Glenn, Johnston Joseph, Kinon Bruce J, Ascher-Svanum Haya, Kollack-Walker Sara, Succop Paul, Naber Dieter
Publicado em 2011-12-01

The relationship, structure and profiles of schizophrenia measurements: a post-hoc analysis of the baseline measures from a randomized clinical trial

Por Chen, Lei, Phillips, Glenn, Johnston, Joseph, Kinon, Bruce J, Ascher-Svanum, Haya, Kollack-Walker, Sara, Succop, Paul, Naber, Dieter
Publicado em 2011

A long-term, phase 2, multicenter, randomized, open-label, comparative safety study of pomaglumetad methionil (LY2140023 monohydrate) versus atypical antipsychotic standard of care...

Por Adams, David H, Kinon, Bruce J, Baygani, Simin, Millen, Brian A, Velona, Isabella, Kollack-Walker, Sara, Walling, David P
Publicado em 2013